Causal inference with observational studies often relies on the assumptions of unconfoundedness and overlap of covariate distributions in different treatment groups. The overlap assumption is violated when some units have propensity scores close to 0 or 1, and therefore both practical and theoretical researchers suggest dropping units with extreme estimated propensity scores. However, existing trimming methods ignore the uncertainty in this design stage and restrict inference only to the trimmed sample, due to the non-smoothness of the trimming. We propose a smooth weighting, which approximates the existing sample trimming but has better asymptotic properties. An advantage of the new smoothly weighted estimator is its asymptotic linearity, which ensures that the bootstrap can be used to make inference for the target population, incorporating uncertainty arising from both the design and analysis stages. We also extend the theory to the average treatment effect on the treated, suggesting trimming samples with estimated propensity scores close to 1.
Introduction
Under the potential outcomes framework, there is an extensive literature on estimating causal effects based on the assumptions of unconfoundedness and sufficient overlap in the covariate distributions (Rosenbaum and Rubin; 1983; Angrist and Pischke; 2008; Imbens and Rubin; 2015) . Unfortunately, in many applications it is common to have limited overlap in covariates between the treatment and control groups, which affects the credibility of all methods attempting to estimate causal effects for the population (King and Zeng; Imbens; 2015) . A consequence in weighting is that extreme propensity scores induce large weights, which can result in a large variance and poor finite sample properties (Kang and Schafer; 2007; Khan and Tamer; . Therefore, it is desirable to modify the estimand to averaging only over the part of the covariate space with treatment probabilities bounded away from 0 and 1. For example, in a medical study of a particular chemotherapy for breast cancer, because patients with stage I breast cancer have never been treated with chemotherapy, clinicians then redefine the study population to be patients with stage II to stage IV breast cancer, omitting patients with stage I breast cancer for whom the propensity score is 0. This effectively alters the estimand by changing the reference population to a different target population. Li et al. (2016) proposed a general representation for the target population.
Trimming observational studies based on estimated propensity scores was first used in medical applications (e.g., Vincent et al.; 2002; Grzybowski et al.; Kurth et al.; and then formalized by Crump et al. Importantly, existing methods, including Crump et al. (2009) , Traskin and Small (2011) and Fogarty et al. (2016) , ignored the uncertainty in this design stage and restricted inference only to the trimmed sample. In contrast, we incorporate uncertainty in both the design and analysis stages. The non-smooth nature of trimming renders the target causal estimand not root-n estimable (Crump et al.; 2009) . Therefore, instead of making a binary decision to include or exclude units from analysis, we propose to use a smooth weight function so that all units are weighted continuously. This smooth weighting approximates the existing sample trimming, but allows us to derive the asymptotic properties of the corresponding causal effect estimators using conventional linearization methods for two-step statistics. We formally show that the new weighting estimators are asymptotically linear, and thus the bootstrap can be used to construct confidence intervals, reflecting the uncertainty in both the design and analysis stages. Nevertheless, we do not argue against other tools for selecting targeted populations, but provide a template to account for uncertainty in the design of observational studies.
Potential outcomes, causal effects and assumptions
For each unit i, the treatment is A i ∈ {0, 1}, where 0 and 1 are labels for control and treatment. There are two potential outcomes, one for treatment and the other for control, denoted by Y i (1) and Y i (0), respectively. The observed outcome is Y i = Y i (A i ). Let X i be the observed pre-treatment covariates. We assume
are independent draws from the distribution of {A, X, Y (1), Y (0)}. Given the observed covariates, the conditional average causal effect is τ (X) = E{Y (1) − Y (0) | X}. The average treatment effect is τ = E{Y (1) − Y (0)} = E{τ (X)}. The common assumptions to identify τ are as follows (Rosenbaum and Rubin; 1983) .
Assumption 2 (Sufficient overlap) There exist constants c 1 and c 2 such that with probability 1, 0 < c 1 ≤ e(X) ≤ c 2 < 1, where e(X) = pr(A = 1 | X) is the propensity score.
In observational studies, the propensity score is not known and therefore has to be estimated from data.
Following Rosenbaum and Rubin (1983) and most of the empirical literature, we assume that the propensity score is correctly specified by a generalized linear model e(X) = e(X θ * ). We focus onθ, the maximum likelihood estimator of the true parameter θ * , although our method is also applicable to other asymptotically linear estimators of θ * . Then, a simple weighting estimator of τ is
If we further estimate µ(a, X) = E(Y | A = a, X) byμ(a, X) and obtain the residualR
then the augmented weighting estimator is N −1 N i=1τ aug (X i ) (Lunceford and Davidian; 2004; Bang and Robins; , whereτ
The augmented weighting estimator features a double robustness property in the sense that under Assumptions 1 and 2, it is consistent for τ if either e(X) or µ(a, X) is correctly specified.
The weighting estimators suffer from a large variability when Assumption 2 is violated or close to be violated. In the presence of lack of overlap, define the set with sufficient overlap to be O = {X | α 1 ≤ e(X) ≤ α 2 }, where α 1 and α 2 are fixed cut-off values; e.g., a rule of thumb suggests α 1 = 0.1 and α 2 = 0.9 (Crump et al.; 2009) . The target population is then represented by O, and the estimand of interest becomes
The trimmed sample based on the estimated propensity score isÔ = {X | α 1 ≤ e(X θ ) ≤ α 2 }. Correspondingly, the inclusion weight is
where 1{·} is the indicator function, and the weighting estimators of τ (O) becomê
The main question addressed in this article is how the estimated support affects the inference. Crump et al. (2009) ignored the uncertainty in estimating O and restricted inferences only for τ (Ô) rather than τ (O). To make inference for τ (O), we need to take into account first the sampling variability inθ, which induces variability of the estimated setÔ and second the sampling variability inτ andτ aug . We can not directly apply conventional asymptotic linearization methods because the weight function (1) is non-smooth.
To avoid this difficulty, we consider a smooth weight function
where Φ (z) is a normal cumulative distribution with mean zero and variance 2 . The normal distribution is can be changed to any distribution as long as it is differentiable and its variance increases with . See Figure 1 for a visualization of different weight functions. As → 0, the smooth weight function (4) converges to the indicator weight function (1). Both the smooth and indicator weight functions include units with non-extreme propensity scores with probability 1. In contrast, another smooth weight function, the overlap weight function ω{e(X)} = e(X){1 − e(X)} recently proposed by Li et al. (2016) , overweighs units with propensity scores close to 0.5 and thus does not target τ (O).
Main Results for the average causal effect
We derive the asymptotic results for the smooth weighting estimators. Based on data {(
, let the score function and the Fisher information matrix of θ be
where f (t) = de(t)/dt. Let σ 2 (a, X) = var(Y | A = a, X) for a = 0, 1. Denote byτ andτ aug the weighting estimators (2) and (3) with the smooth weight function (4), respectively. Let τ = E{ω (X θ * )τ (X)} and ω (θ) = E{ω (X θ)}. We show thatτ andτ aug are consistent for τ . Moreover, the discrepancy between τ and the target estimand τ (O) can be made arbitrarily small by choosing a small .
Theorem 1 Under Assumption 1,τ is asymptotically linear. Moreover,
in distribution, as N → ∞, where
Remark 1 We show in the Supplementary Material that b 1, → 0, as → 0. Therefore, the increased variability due to estimating the support, b 1, I(θ * ) −1 b 1, , is close to 0 with a small .
Remark 2
The term −b 2, I(θ * ) −1 b 2, implies that the estimated propensity score increases the precision of the simple weighting estimator of τ based on the true propensity score, a phenomenon that has previously appeared in the missing data and causal inference literature (e.g., Rubin and Thomas; 1992; Hahn; 1998; Abadie and Imbens; .
Theorem 2 Under Assumption 1,τ aug is asymptotically linear. Moreover,
Remark 3 If the outcome model is correctly specified, thenμ(a, X) = µ(a, X) and thus C 0 = C 1 = 0. Consequently, the asymptotic variance ofτ aug reduces toσ 2 + b 1 I(θ * ) −1 b 1 , which is smaller than the asymptotic variance ofτ . Intuitively, by regressing Y on X and A, we use the residual as the new outcome, which in general has a smaller variance than Y .
Remark 4 Becauseτ andτ aug are asymptotically linear, the bootstrap can be used to estimate the variances ofτ andτ aug (Shao and Tu; 2012) . Let S = {X | e(X θ * ) = α 1 or α 2 }. If pr(X ∈ S) = 0, we show in the Supplementary Material that the bootstrap works for the weighting estimator with the indicator function, which will also be demonstrated in the simulation study.
Remark 5 Although some robust nonparametric methods (Hirano et al.; Lee et al.; can be used for propensity score estimation, the majority of the literature used a parametric generalized linear model.
When the propensity score model is misspecified, the weighting estimators are not consistent to the causal effect defined on the target population O = {X | α 1 ≤ e(X) ≤ α 2 }. However, our estimators can still be helpful to inform treatment effects for the population defined as
e(X θ * ) is the propensity score projected to the generalized linear model family. This new study population is defined as between two hyperplanes of the covariate space, which is just slightly more complicated than the study population defined by the trees in Traskin and Small (2011) or by the intervals of covariates in Fogarty et al. (2016) . Moreover, the smooth weighting estimators are still asymptotically linear, and again the bootstrap can be used for constructing confidence intervals. See the Supplementary Material for more details.
Remark 6 An important issue regarding the smooth weight function is the choice of , which involves a bias-variance trade-off. On the one hand, the discrepancy between τ and the target parameter τ (O) is
is integrable, by the Dominated Convergence Theorem, τ converges to τ (O) as → 0. This implies that our inference based onτ orτ aug , by choosing a small , can be drawn for τ (O). On the other hand, as → 0, the smooth weight function (4) becomes closer to the indicator weight function (1), which increases the variance of the weighting estimators.
In practice, we recommend a sensitivity analysis varying over a grid, for example, {10 −4 , 10 −5 , . . .}, which will be illustrated in the simulation and application.
Simulation
We assess the performance of the new weighting estimators of the average treatment effect over a target population. We consider X = (X 1 , X 2 , X 3 , X 4 , X 5 , X 6 ) , where X 1 , X 2 , and X 3 are multivariate normal with means (0, 0, 0), variances (2, 1, 1) and covariances (1, −1, −0.5), X 4 ∼ Uniform[−3, 3], X 5 ∼ χ 2 1 , and X 6 ∼ Bernoulli(0.5). The treatment indicator A is generated from Bernoulli{e(X)}. We consider four propensity score deigns:
(P1) and (P3) represent week separations, and (P2) and (P4) represent strong separations of propensity score distributions between the treatment and control groups. We consider both linear and nonlinear outcome designs:
The target population is represented by O = {X | 0.1 ≤ e(X) ≤ 0.9}, and the estimand of interest is the average treatment effect over the target population τ (O).
We consider the weighting estimators with the indicator and smooth weight functions, and
} for benchmark comparison with N = 500. The propensity scores are estimated by a logistic regression model with linear predictors X. Therefore, the propensity score model is correctly specified under (P1) and (P2) but misspecified under (P3) and (P4). For the augmented weighting estimators, µ(a, X) is estimated by a simple linear regression of Y on X, separately for A = 0, 1. Therefore, the outcome regression model is correctly specified under (O1) but misspecified under (O2). Table 1 shows the simulation results. Under Scenarios i, ii, v and vi when the propensity score model is correctly specified, the weighting estimators are nearly unbiased of τ (O), and the augmented weighting estimators are more efficient than the simple weighting estimators. However, under Scenarios iii, iv, vii and viii when the propensity score model is misspecified, all estimators are biased, even when the outcome regression model is correctly specified. The weighting estimators with the smooth weight function,τ and τ aug , show slightly smaller variances than the counterparts with the indicator weight function,τ andτ aug . Moreover, as becomes smaller, the performances ofτ andτ aug become closer to those ofτ andτ aug . The bootstrap works well with the variance estimates close to the true variances for all estimators.
The National Health and Nutrition Examination Survey Data
We examine a data set from the 2007-2008 U.S. National Health and Nutrition Examination Survey to estimate the causal effect of smoking on blood lead levels (Hsu and Small; 2013) . The data set includes 3340 subjects consisting of 679 smokers, denoted as A = 1, and 2661 nonsmokers, denoted as A = 0. The outcome variable Y is the measured lead level in blood, with the observed range from 0.18 ug/dl to 33.10 ug/dl. The covariate vector X includes age, income-to-poverty level, gender, education and race.
The propensity score is estimated by a logistic regression model with linear predictors including all covariates. To help address lack of overlap, for the average smoking effect, because there is little overlap for the propensity score less than 0.05 and greater than 0.6, we restrict our estimand to the target population O = {X | 0.05 ≤ e(X) ≤ 0.6}. This results in removal of 794 subjects, with 111 smokers and 683 nonsmokers. Thus, the analysis sample includes 2546 subjects, with 568 smokers and 1978 non-smokers. We consider the weighting estimators using both the indicator and smooth weight functions with = 10 −4 and = 10 −5 . For the augmented weighting estimator, we consider the outcome model to be a linear regression model adjusting for all covariates, separately for A = 0, 1. 6 Extension to the average treatment effect on the treated is reasonable to drop these units with e(X) close to 1 when inferring τ ATT . We give a formal discussion in the Supplementary Material.
By restricting the focus to the optimal set O = {X | 1 − e(X) ≥ α}, the estimand of interest be-
We propose two estimators with smooth inclusion weights
, which are (2) and (3) with ω (X θ ) replaced by ω ATT, (X θ ). Therefore, the asymptotic properties forτ ATT, andτ aug ATT, can be derived similarly as in Theorems 1 and 2. In particular, the asymptotic linearity enables the bootstrap for inference. Defineb 1, andb 2, as the analogs of b 1, and b 2, with weights ω ATT, (X θ ). In contrast to Remark 1, for τ ATT ,b 1, does not converge to 0 as → 0. The correction term in the asymptotic variance formula due to the estimated propensity score instead of the true propensity score,b 1, I(θ * ) −1b 1, −b 2, I(θ * ) −1b 2, , can be negative, zero, or positive. Ignoring the uncertainty in the estimated propensity score, the inference can be either conservative or anti-conservative for τ ATT , which differs from the inference for τ . This fundamental difference also appeared for matching estimators (Abadie and Imbens; , which highlights the importance of incorporating the uncertainty in the design stage especially for τ ATT .
Supplementary Material
Section S7 gives all the proofs, and Section S8 extends the theory to the average treatment effect on the treated.
Below we use
Becauseθ is the solution to the score equation S(θ) = 0, under certain regularity conditions,θ − θ * = J (θ * ) −1 S(θ * ) + o p (N −1/2 ), where J (θ * ) = E{∂S(θ * )/∂θ } (van der Vaart; 2000) . When the propensity model is correctly specified, then J (θ * ) = I(θ * ); but when the propensity score model is misspecified, J (θ * ) is not necessarily equal to I(θ * ).
S7 Proofs

S7.1 Proof of Theorem 1
We writeτ
where (S1) follows from the Taylor expansion, (S2) follows fromθ − θ * ∼ = I(θ * ) −1 S(θ * ) and
Therefore, the asymptotic linearity ofτ follows. Moreover,
where τ {e(X θ * )} = E{Y (1) − Y (0) | e(X θ * )}, and by grouping different terms,
and
Define
By conditioning arguments, E(T 0 ) = 0, for k = 1, . . . , 3, E(T k ) = E{E(T k | F k−1 )} = 0, and for k = 1, . . . , 3,
Also, we calculate the variances of T i , for i = 0, . . . , 3, as follows. For T 0 ,
For T 1 ,
For T 2 ,
var{X | e(X θ * )} e(X θ * ){1 − e(X θ * )} B.
For T 3 ,
.
we have
where b 1, and b 2, are defined in Theorem 1. Therefore, according to (S3), B = (b 1, − b 2, ) I(θ * ) −1 . As a result,
where σ 2 is defined as the terms from (S5) to (S6), and the last equality follows by plugging the expression of B,
Moreover, σ 2 can be further simplified as
Finally, the Central Limit Theorem implies
S7.2 Proof of Theorem 2
First,τ aug (X i ) can also be written aŝ
Therefore, the asymptotic linearity ofτ aug follows. Moreover,
whereT 3 = T 3 is defined in (S4),
By the same argument as in the proof of Theorem 1, E(T j ) = 0, for j = 0, . . . , 3, and cov(T j ,T k ) = 0 for all
whereσ 2 , C 0 and C 1 are defined in Theorem 2. Because
S7.3 Proof of Remark 1
We show that
goes to zero, as → 0. We note
and φ (x) = dΦ (x)/dx. As → 0, φ (x) → 0 implies that b 1, goes to 0.
S7.4 Proof of Remark 4
We writê
is finite and well-defined, because the only possible problem that prevents the use of the bootstrap is the derivative of the indicator function with respect to θ which however has a zero measure. Therefore,τ is asymptotically linear. From Shao and Tu (2012) , the bootstrap can be used to estimate var(τ ). A similar discussion applies toτ aug .
S7.5 Proof of Remark 5
where
Therefore, the asymptotic linearity ofτ follows.
Therefore, the asymptotic linearity ofτ aug follows.
The asymptotic linearity of the weighting estimators allows for the bootstrap to construct confidence intervals.
S8 Average treatment effect on the treated S8.1 Notation, Assumptions and Extension of Crump et al. (2009) Another estimand of interest is the average treatment effect for the treated
The outcome distribution for the treated is empirically identifiable, because
. Therefore, Assumptions 1 and 2 can be weakened (Heckman et al.; 1997) .
Assumption S4 There exists a constant c such that with probability 1, e(X) ≤ c < 1.
A simple weighting estimator (Hirano et al.; Mercatanti and Li; 2014; Shinozaki and Matsuyama; 2015) isτ
which is a special case of the weighting estimator (4) by choosing ω(X iθ ) = e(X iθ ). Analogously, the augmented weighting estimator (Mercatanti and Li; 2014) iŝ
There is a limited literature dealing with lack of overlap for τ ATT when Assumption S4 may not hold. Dehejia and Wahba (1999) suggested dropping all control units with an estimated propensity score lower than the smallest value for the estimated propensity score among the treated units. Heckman et al. (1997) and Smith and Todd (2005) proposed discarding units with covariate values at which the estimated density is below some threshold. However, few formal results have been established on properties of these procedures.
Similar to Crump et al. (2009) , if σ 2 (1, X) = σ 2 (0, X), we can show that the optimal overlap for estimating τ ATT is of the form O = {X | 1 − e(X) ≥ α} for some α, for which the estimators have smallest asymptotic variance. Intuitively, for the treated units with e(X) close to 1, there are no similar units in the control group that can provide adequate information to infer Y (0) for these treated units. Statistically, the control units with e(X) close to 1 contribute to large weights. Therefore, it is reasonable to drop these units with e(X) close to 1. By restricting the focus to the optimal set, the estimand of interest becomes τ ATT (O) = E{τ (X) | A = 1, X ∈ O}. Below, we formalize this argument.
S8.2 Theory of trimming for the average treatment effect on the treated
Define a general weighting average treatment effect,
According to the technique report in 2006 prior to Crump et al. (2009) , the efficiency bound for τ ω (O) is V ω (O) = 1 [E{ω(X) | X ∈ O}] 2 E ω(X) 2 σ 2 (1, X) e(X) + σ 2 (0, X) 1 − e(X) | X ∈ O . (S13) Crump et al. (2009) showed that the optimal set with whichτ ω (O) achieves the smallest asymptotic variance over all choices of O is where γ is defined through the following equation:
E ω 2 (X) 
We identify that the weighting estimator for the average treatment effect on the treated is (S12) with ω(X) = e(X). Assuming that σ 2 (1, X) = σ 2 (0, X) = σ 2 , the optimal set (S14) reduces to O = {x | 1 − e(x) ≥ α} with the cut-off value α = σ 2 /γ. In practice, α can be determined by the smallest value of α that satisfy the empirical estimate of equation (S15):
The choice of α in O = {X | 1 − e(X) ≥ α} has two opposite effects on the asymptotic variance in (S13).
On the one hand, as α increases, we reduce the denominator of the right hand side of (S13), [E{ω(X) | X ∈ O}] 2 = E[{e(X) | X ∈ O}] 2 , and therefore increase the asymptotic variance. On the other hand, as α increases, we decrease the numerator of the right hand side of (S13), E ω(X) 2 σ 2 (1, X) e(X) + σ 2 (0, X) 1 − e(X) | X ∈ O = E e(X)σ 2 (1, X) + e(X) 2 σ 2 (0, X) 1 − e(X) | X ∈ O , and therefore decrease the asymptotic variance. The optimal value of α balances the two effects.
S8.3 The National Health and Nutrition Examination Survey Data
For the average smoking effect on the smokers, subjects are trimmed if their estimated propensity score is greater than 0.7. This results in removal of 36 subjects, with 29 smokers and 7 non-smokers. Thus, the analysis sample includes 3304 subjects, with 650 smokers and 2654 non-smokers. Following the main paper for the average treatment effect, we consider the weighting estimators using both the indicator and smooth weight functions with = 10 −4 and = 10 −5 . For the augmented weighting estimator, we consider the outcome model to be a linear regression model adjusting for all covariates, separately for A = 0, 1. Table S3 shows the results from the estimators for the average smoking effect on the smokers based on the trimmed samples. The weighting estimators with the smooth weight function are close to the counterparts with the indicator weight function, but have slightly smaller standard errors. The smooth weighting estimators are insensitive to the choice of . From the results, on average, smoking increases the lead level in
